AR050732A1 - 15 beta-sustituidos esteroides con actividad estrogenica selectiva - Google Patents
15 beta-sustituidos esteroides con actividad estrogenica selectivaInfo
- Publication number
- AR050732A1 AR050732A1 ARP050103745A ARP050103745A AR050732A1 AR 050732 A1 AR050732 A1 AR 050732A1 AR P050103745 A ARP050103745 A AR P050103745A AR P050103745 A ARP050103745 A AR P050103745A AR 050732 A1 AR050732 A1 AR 050732A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- beta
- selective
- activity
- strogen
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 2
- 150000003431 steroids Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 230000003637 steroidlike Effects 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 abstract 1
- 125000006593 (C2-C3) alkynyl group Chemical group 0.000 abstract 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 102000015694 estrogen receptors Human genes 0.000 abstract 1
- 108010038795 estrogen receptors Proteins 0.000 abstract 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 abstract 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04104334 | 2004-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR050732A1 true AR050732A1 (es) | 2006-11-15 |
Family
ID=34929554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050103745A AR050732A1 (es) | 2004-09-08 | 2005-09-08 | 15 beta-sustituidos esteroides con actividad estrogenica selectiva |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7838516B2 (enExample) |
| EP (1) | EP1805201B1 (enExample) |
| JP (1) | JP4889644B2 (enExample) |
| AR (1) | AR050732A1 (enExample) |
| AT (1) | ATE414710T1 (enExample) |
| AU (1) | AU2005281705B2 (enExample) |
| BR (1) | BRPI0514976A (enExample) |
| CA (1) | CA2577497C (enExample) |
| DK (1) | DK1805201T3 (enExample) |
| ES (1) | ES2317312T3 (enExample) |
| NZ (1) | NZ553266A (enExample) |
| PE (1) | PE20060590A1 (enExample) |
| PL (1) | PL1805201T3 (enExample) |
| PT (1) | PT1805201E (enExample) |
| RS (1) | RS51640B (enExample) |
| RU (1) | RU2386637C2 (enExample) |
| SI (1) | SI1805201T1 (enExample) |
| TW (1) | TW200621795A (enExample) |
| UA (1) | UA89964C2 (enExample) |
| WO (1) | WO2006027347A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8030298B2 (en) | 2005-05-26 | 2011-10-04 | Abbott Products Gmbh | 17β-HSD1 and STS inhibitors |
| US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
| US8288367B2 (en) | 2006-11-30 | 2012-10-16 | Solvay Pharmaceuticals Gmbh | Substituted estratriene derivatives as 17BETA HSD inhibitors |
| WO2011000540A1 (en) * | 2009-06-29 | 2011-01-06 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing 3,3,5,5-tetramethylcyclohexanone |
| US20120116125A1 (en) * | 2009-06-29 | 2012-05-10 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing neramexane |
| PL2448910T3 (pl) * | 2009-06-29 | 2013-10-31 | Merz Pharma Gmbh & Co Kgaa | Sposób wytwarzania nerameksanu |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| SI2764008T1 (sl) * | 2011-10-07 | 2016-10-28 | Estetra S.P.R.L. | Postopek za pripravo estetrola |
| CN105518015B (zh) | 2013-06-25 | 2017-09-15 | 佛恩多制药有限公司 | 治疗活性的作为17β‑羟基类固醇脱氢酶抑制剂的17‑氮取代雌三烯噻唑衍生物 |
| EP3013845B1 (en) | 2013-06-25 | 2020-03-18 | Forendo Pharma Ltd | Therapeutically active estratrienthiazole derivatives as inhibitors of 17b-hydroxysteroid dehydrogenase, type 1 |
| US9850272B2 (en) | 2013-06-25 | 2017-12-26 | Forendo Pharma Ltd. | Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1 |
| WO2016102775A1 (en) | 2014-12-23 | 2016-06-30 | Forendo Pharma Ltd | PRODRUGS OF 17β-HSD1 -INHIBITORS |
| WO2016102776A1 (en) | 2014-12-23 | 2016-06-30 | Forendo Pharma Ltd | Prodrugs of 17.beta.-hsd1 -inhibitors |
| KR102662025B1 (ko) | 2015-06-18 | 2024-05-02 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 에스테트롤 성분을 함유하는 구강분해성 투여 단위 |
| HUE054551T2 (hu) | 2015-06-18 | 2021-09-28 | Estetra Sprl | Ösztetrolt tartalmazó, szájban diszpergálódó tabletta |
| NZ737948A (en) | 2015-06-18 | 2023-03-31 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
| LT3310345T (lt) | 2015-06-18 | 2021-06-25 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| NZ760155A (en) | 2017-06-08 | 2022-09-30 | Forendo Pharma Ltd | 15.beta.-[3-propanamido]-substituted estra-1,3,5 |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| KR20210114390A (ko) | 2018-12-05 | 2021-09-23 | 포렌도 파마 리미티드 | 17-hsd1의 억제제로서의 피라졸 고리와 위치 16(17)에서 축합된 에스트라-1,3,5(10)-트리엔 화합물 |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL226738A (enExample) | 1957-04-11 | |||
| DE1084261B (de) | 1957-04-11 | 1960-06-30 | Syntex Sa | Verfahren zur Herstellung neuer Cyclopentanophenanthrenderivate |
| US3257429A (en) * | 1957-11-12 | 1966-06-21 | Syntex Corp | 16-methylene derivatives of estrone and estradiol |
| US3007946A (en) | 1958-11-06 | 1961-11-07 | Searle & Co | 3-alkoxy-16-methylene-1, 3, 5(10)-estratrien-17-ones |
| US3049555A (en) | 1959-12-22 | 1962-08-14 | Searle & Co | 3-alkoxy-16-methyl-1, 3, 5 (10)-estratrien-17-ones |
| US3092645A (en) | 1961-12-28 | 1963-06-04 | Searle & Co | Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols |
| GB1110792A (en) | 1964-04-07 | 1968-04-24 | Res Inst Medicine Chem | Novel 5(10)-dehydro-steroids |
| US3299108A (en) | 1965-10-18 | 1967-01-17 | Searle & Co | 17alpha-alkynyl/alkenyl-13beta-alkyl-11-alkylgona-1, 3, 5 (10)-triene-3, 17beta-diols, ethers and esters thereof and intermediates thereto |
| US3465010A (en) | 1966-11-22 | 1969-09-02 | Searle & Co | 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof |
| US3377366A (en) | 1966-12-02 | 1968-04-09 | Searle & Co | 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof |
| US3642992A (en) * | 1967-09-08 | 1972-02-15 | Upjohn Co | Organic compounds |
| ZA712312B (en) | 1970-04-28 | 1972-01-26 | Ochsner Med Found Alton | 4,14-estradiene compounds |
| US3652606A (en) | 1970-08-07 | 1972-03-28 | Searle & Co | 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof |
| US3704253A (en) | 1970-09-23 | 1972-11-28 | American Home Prod | 13 - polycarbonalkyl - 16 - methylgona-1,3,5(10)-trienes and 13-polycarbonalkyl-16-methylgon - 4 - en-3-ones and intermediates for their production |
| US3766224A (en) * | 1971-06-03 | 1973-10-16 | Sandoz Ag | 15-methyl-substituted steroids |
| FR2377419A1 (fr) | 1977-01-13 | 1978-08-11 | Roussel Uclaf | Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament |
| DE2757157C3 (de) | 1977-12-19 | 1980-10-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 16 a -alkylierten Steroiden |
| AU572589B2 (en) | 1983-12-14 | 1988-05-12 | Upjohn Company, The | 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids |
| US5116830A (en) | 1984-08-17 | 1992-05-26 | Sri International | Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses |
| US5204337A (en) | 1988-10-31 | 1993-04-20 | Endorecherche Inc. | Estrogen nucleus derivatives for use in inhibition of sex steroid activity |
| ZA94715B (en) | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
| AU671706B2 (en) | 1993-03-05 | 1996-09-05 | Akzo N.V. | Use of a Pregnane Derivative |
| CA2200423C (en) | 1996-03-26 | 2006-12-19 | Sietse Mosselman | Novel estrogen receptor |
| TW403736B (en) | 1997-02-21 | 2000-09-01 | Akzo Nobel Nv | Steroid compounds having contraceptive and anti-osteoporosis activity |
| PL343428A1 (en) | 1998-03-09 | 2001-08-13 | Akzo Nobel Nv | New contraceptive kit |
| CN1172949C (zh) | 1998-06-19 | 2004-10-27 | 阿克佐诺贝尔公司 | 睾酮衍生物 |
| ATE222922T1 (de) | 1998-11-20 | 2002-09-15 | Akzo Nobel Nv | Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11 |
| TW548277B (en) | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
| JP2003508541A (ja) | 1999-09-06 | 2003-03-04 | アクゾ・ノベル・エヌ・ベー | １１位に炭化水素置換基を有する非芳香族エストロゲンステロイド |
| JP2003513102A (ja) * | 1999-11-02 | 2003-04-08 | シエーリング アクチエンゲゼルシャフト | 選択的な作用を有するエストロゲンとしての１８−ノル−ステロイド |
| HUP0301592A2 (hu) * | 2000-07-28 | 2003-09-29 | Akzo Nobel N.V. | 16alfa-metil- vagy etil-szubsztituált ösztrogének és ezeket tartalmazó gyógyszerkészítmények |
-
2005
- 2005-05-09 UA UAA200701655A patent/UA89964C2/ru unknown
- 2005-09-02 TW TW094130148A patent/TW200621795A/zh unknown
- 2005-09-05 EP EP05794597A patent/EP1805201B1/en not_active Expired - Lifetime
- 2005-09-05 AT AT05794597T patent/ATE414710T1/de active
- 2005-09-05 US US11/662,166 patent/US7838516B2/en active Active
- 2005-09-05 RS RS20070075A patent/RS51640B/sr unknown
- 2005-09-05 JP JP2007530702A patent/JP4889644B2/ja not_active Expired - Fee Related
- 2005-09-05 SI SI200530582T patent/SI1805201T1/sl unknown
- 2005-09-05 ES ES05794597T patent/ES2317312T3/es not_active Expired - Lifetime
- 2005-09-05 DK DK05794597T patent/DK1805201T3/da active
- 2005-09-05 BR BRPI0514976-2A patent/BRPI0514976A/pt not_active IP Right Cessation
- 2005-09-05 PT PT05794597T patent/PT1805201E/pt unknown
- 2005-09-05 RU RU2007112939/04A patent/RU2386637C2/ru not_active IP Right Cessation
- 2005-09-05 CA CA2577497A patent/CA2577497C/en not_active Expired - Fee Related
- 2005-09-05 PL PL05794597T patent/PL1805201T3/pl unknown
- 2005-09-05 WO PCT/EP2005/054368 patent/WO2006027347A1/en not_active Ceased
- 2005-09-05 NZ NZ553266A patent/NZ553266A/en not_active IP Right Cessation
- 2005-09-05 AU AU2005281705A patent/AU2005281705B2/en not_active Ceased
- 2005-09-06 PE PE2005001026A patent/PE20060590A1/es not_active Application Discontinuation
- 2005-09-08 AR ARP050103745A patent/AR050732A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1805201T3 (da) | 2009-01-12 |
| CA2577497C (en) | 2012-03-20 |
| EP1805201B1 (en) | 2008-11-19 |
| US20070254860A1 (en) | 2007-11-01 |
| WO2006027347A1 (en) | 2006-03-16 |
| JP2008512426A (ja) | 2008-04-24 |
| PT1805201E (pt) | 2008-12-31 |
| ATE414710T1 (de) | 2008-12-15 |
| PE20060590A1 (es) | 2006-07-14 |
| RU2007112939A (ru) | 2008-11-10 |
| NZ553266A (en) | 2009-06-26 |
| AU2005281705B2 (en) | 2011-03-10 |
| US7838516B2 (en) | 2010-11-23 |
| RU2386637C2 (ru) | 2010-04-20 |
| TW200621795A (en) | 2006-07-01 |
| CA2577497A1 (en) | 2006-03-16 |
| EP1805201A1 (en) | 2007-07-11 |
| ES2317312T3 (es) | 2009-04-16 |
| RS20070075A (sr) | 2008-09-29 |
| PL1805201T3 (pl) | 2009-04-30 |
| AU2005281705A1 (en) | 2006-03-16 |
| UA89964C2 (ru) | 2010-03-25 |
| BRPI0514976A (pt) | 2008-07-01 |
| RS51640B (sr) | 2011-10-31 |
| SI1805201T1 (sl) | 2009-04-30 |
| JP4889644B2 (ja) | 2012-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR050732A1 (es) | 15 beta-sustituidos esteroides con actividad estrogenica selectiva | |
| PE20120049A1 (es) | Derivados de 3-anilino-tieno[3, 2-c]piridina como inhibidores de quinasa mek | |
| CR11181A (es) | Derivados de ftalazinona | |
| CY1110491T1 (el) | Διαμορφωτες του υποδοχεα γλυκοκορτικοειδους αζαδεκαλινης | |
| AR049089A1 (es) | Derivados de adamantil pirrolidin -2- ona como inhibidores de 11-beta hidroxiesteroide deshidrogenasa | |
| EP1972470A4 (en) | AIR SUPPLY DEVICE | |
| FR2884327B3 (fr) | Alimentation avec un dispositif d'affichage de performance | |
| AR024746A1 (es) | Androgenos oralmente activos. | |
| ATE433454T1 (de) | Pyrazoloä1,5-aüpyrimidine als antagonisten des adenosin-a2a-rezeptors | |
| UY30384A1 (es) | Formas cristalinas de 11b-(4-acetilfenil)-20,20,21,21,21-pentafluoro-17-hidroxi-19-nor-17a-pregna-4,9-dien-3-ona | |
| EP1837562A4 (en) | SEALING DEVICE WITH SOUND INSULATING SEAL | |
| PE20141169A1 (es) | Derivados de etinilo | |
| BRPI0513902A (pt) | novos derivados de 4-benzilideno-piperidina | |
| WO2008111632A1 (ja) | ２，２，４－トリメチル－６－フェニル－１，２－ジヒドロキノリン誘導体からなるグルココルチコイド受容体アゴニスト | |
| FR2873863B1 (fr) | Dispositif d'alimentation en energie | |
| CO6150165A2 (es) | Nevos derivados 5,7-disustituidos de [1,3]tiazolo[4,5-d]pirimidin-2 (3h)-ona y su uso en terapia | |
| ECSP077305A (es) | ESTEROIDES SUSTITUIDOS EN LA POSICIÓN 15b QUE TIENEN ACTIVIDAD ESTROGÉNICA SELECTIVA | |
| CN205840401U (zh) | 一种带有桑拿房的淋浴室 | |
| DE602004005177D1 (de) | Schnürvorrichtung | |
| NO20075505L (no) | 7-fluor-1,3-dihydro-indol-2-on oksazolidinoner som antibakterielle forbindelser | |
| ATE477951T1 (de) | Vorrichtung zum dichten und dämpfen | |
| PE20071170A1 (es) | Compuestos derivados de sulfonamida como moduladores del receptor glucocorticoide | |
| EP1533312A4 (en) | HETEROBICYCLIC COMPOUNDS | |
| MY143679A (en) | 15b-subsitituded streoids having selective estrogenic activity | |
| FR2970754B1 (fr) | Dispositif de fixation d'un accessoire sur une paroi support en materiau dur |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |